AtaCor Medical develops extravascular cardiac pacing and defibrillation lead systems that eliminate the need for transvenous access, reducing the risks and complications associated with traditional methods. Their technology enables reliable temporary pacing and defibrillation while allowing for safe patient ambulation post-procedure.
Funding
$28M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional cardiac pacing and defibrillation methods rely on transvenous leads, which can lead to complications such as infections, thrombosis, and lead dislodgement, potentially compromising the heart and vasculature for future interventions. These methods necessitate placement within the heart, posing risks to long-term patient health and limiting options for subsequent cardiac care.
Solution
AtaCor Medical is developing extravascular cardiac pacing and defibrillation lead systems designed to eliminate the need for transvenous access, thereby reducing the risks and complications associated with traditional methods. The AtaCor EV Temporary Pacing System delivers reliable, imaging-free temporary pacing without entering the heart or vascular system, enabling safe post-procedure ambulation. The AtaCor EV-ICD Lead System, featuring a streamlined parasternal approach, is being designed to provide reliable bradycardia pacing, ATP, and defibrillation without touching the heart, and is compatible with commercially available transvenous ICDs.
Target Audience
The primary target audience includes electrophysiologists and cardiologists seeking to minimize complications associated with transvenous leads in patients requiring temporary pacing or implantable cardioverter-defibrillators (ICDs).
Features
- Extravascular lead placement, avoiding the heart and vasculature
- Temporary Pacing System delivers reliable pacing without fluoroscopy
- Eliminates complications associated with transvenous leads
- Enables safe patient ambulation post-procedure for temporary pacing
- EV-ICD Lead System features a streamlined parasternal approach
- EV-ICD System delivers bradycardia pacing, ATP and defibrillation
- EV-ICD System is compatible with commercially available ICDs